Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Historical indication, duration and organism material is retained. This import does not establish that these are preferred current treatment choices.
Check source scope before reading a dose
UCSF - levofloxacin
Product / population
Adult systemic levofloxacin; treatment regimens. Heme/BMT prophylaxis is a separate source regimen.
Renal method
CrCl in mL/min where specified; no equation inferred.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Select the usual regimen before the renal row
The 750, 500 and 250 mg renal paths differ. The 250 mg row has a specific uncomplicated-UTI exception and lacks dialysis adjustment information.
What to reconcile: Retain indication, usual dose, loading dose and maintenance interval together.
For CrCl >50 / 20-49 / <20 mL/min, UTI treatment uses 500 mg IV/orally daily / 500 mg once then 250 mg daily / 500 mg once then 250 mg every 48 hours. Other infections use 750 mg daily / 750 mg every 48 hours / 750 mg once then 500 mg every 48 hours.
IHD standard: 500 mg once then 250 mg every 48 hours. IHD pneumonia, Gram-negative bacteremia or Pseudomonas: 750 mg once then 500 mg every 48 hours.
CVVHD standard: 750 mg once then 250 mg daily; pneumonia/bacteremia/Pseudomonas: 750 mg once then 500 mg IV daily. Oral doses require separation from multivalent cations by at least 2 hours.
The exact CrCl 50 boundary is not allocated by the displayed >50 / 20-49 columns.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.